Weishi Medical released its 2025 performance forecast on February 26, reporting a total revenue of 463 million yuan during the period, a year-on-year increase of 15.66%; net profit attributable to shareholders of the listed company was 137 million yuan, a year-on-year increase of 33.99%; basic earnings per share were 1.43 yuan.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Weisi Medical Performance Brief: Net profit attributable to parent company in 2025 is 137 million yuan, a year-on-year increase of 33.99%
Weishi Medical released its 2025 performance forecast on February 26, reporting a total revenue of 463 million yuan during the period, a year-on-year increase of 15.66%; net profit attributable to shareholders of the listed company was 137 million yuan, a year-on-year increase of 33.99%; basic earnings per share were 1.43 yuan.